# Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder

> **NCT03683472** · NA · COMPLETED · sponsor: **MindSciences, Inc.** · enrollment: 65 (actual)

## Conditions studied

- Anxiety Disorders

## Interventions

- **BEHAVIORAL:** Unwinding Anxiety Phone App

## Key facts

- **NCT ID:** NCT03683472
- **Lead sponsor:** MindSciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-20
- **Primary completion:** 2019-10-17
- **Final completion:** 2019-10-17
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2020-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03683472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03683472, "Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03683472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*